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Abstract 
Chronic diseases and their treatment regimen plays a greater role in determining the patient related health outcomes 
of which one is Health Related Quality of Life. Hypertension itself along with its pharmacotherapy impacts 
HRQoL of hypertensive patients. The primary objective of the study was to determine the impact of f hypertensive 
medications on the health-related quality of life among hypertensive patients with the secondary objective to assess 
which medication significantly affects health related quality of life of hypertensive patients. A quantitative 
questionnaire based cross-sectional survey was undertaken in outpatient departments of Sandeman Provisional 
Hospital (SPH) Quetta using an EQ-5D-3L to determine the Health-Related Quality of Life. Convenience 
Sampling technique was used for data collection. Majority of respondents (8.7%) had no problem in first three 
domains while having some problem in pain and anxiety domains. Following them 7.6% of patients had some 
problems in all domains of the EQ5D tool. Moreover. the ACE Inhibitors and Diuretics impacts HRQoL of patients 
of current study. A total of 263 participated in the study of which (25%) of the respondents were of age group 48 
-75 years old and were married 73.4% mostly. Majority (8.7%) had no problem in first three domains while having 
some problem in pain and anxiety domains. ACE Inhibitors and Diuretics significantly influence the health status 
of hypertensive patients acquiring pharmacotherapy. It was concluded that antihypertensive agents have a 
significant impact on HRQoL of hypertensive patients especially Angiotensin Converting Enzymes and Diuretics, 
which show significant impact on HRQoL of hypertensive patients. However, it is also suggested to assess the 
impact of antihypertensive therapies given in combination must also be studied in order to provide health 
professionals a better understanding of their prescribed regimen to improve patient related health outcomes.  
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1. Introduction 
Hypertension is a continuing health problem of immense public health concern globally especially for developing 
world [1]. In 2010, 1.39 billion individuals globally were living with increased blood pressure, and out of those, 
1.04 billion were from Lower Middle-Income Countries and 349 million in Higher Income Countries [2]. It was 
projected that in the year 2025, the number may increase to 60% to a total of 1.56 billion [3]. 
Globally, half of the total death toll caused by stroke and heart disease is due to hypertension. It is the most 
important risk factor for cardiovascular diseases [3]. Number of interventions, pharmacological and non-
pharmacological, have been designed for the purpose of treating hypertension. Despite of having antihypertensives’ 
influence on lowering the risk of stroke, coronary heart disease, congestive heart failure, and mortality they also 
impose a greater effect on an individual’s life style and their Health related quality of life [4, 5]. The 
pharmacological treatment along with the disease itself has been reported to have side effects that moderately have 
an adverse effect on an individual’s Health-related quality of life especially the psychological domain [4, 6], 
however, the improvement in health related quality of life has also been evidenced by the studies [4]. The 
consequence of their adverse effect on health related quality of life was reported as poor compliance to 
antihypertensive treatment and deterioration of symptoms [6].  
Health Related Quality of Life therefore can be defined as individuals perceived quality of life representing 
satisfaction in those areas of life likely to be affected by health status [7-9]. "Health-related quality of life" (HRQoL) 
integrates aspects of physical, psychological, and social health, as defined by the World Health Organization in 
1948 [8]. Patients with chronic conditions often suffer from prolonged physical and psychological distress, which 
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deteriorates quality of life and leads to decreased life expectancy [10, 11]. The development of chronic conditions 
with established decreased life expectancies is very disturbing for the patients. The complex nature of diseases and 
sometimes their treatments has stressful effect on social and economic status of the patients. HRQoL can be altered 
by both the immediate and long-term treatment effects, especially in the chronic disease setting. Even in the 
controlled status the feeling of being ill heavily imbalances the quality of life (QoL) [7].  
There has been considerable number of studies conducted on determining HRQoL of hypertensive patients but 
hardly any studies have been reported so far which has determined HRQoL of hypertensive patients who have 
been on the hypertensive pharmacotherapy in Pakistan and especially in the city of Quetta. Therefore, the primary 
objective of the study was to determine the impact of f hypertensive medications on the health-related quality of 
life among hypertensive patients with the secondary objective to assess which medication significantly affects 
health related quality of life of hypertensive patients. 
Understanding the quality of life of hypertensive subjects as well as aspects that pharmacological and non-
pharmacological interventions affect them may contribute health care professionals in evolving and applying 
interventions targeted at improving anti-hypertensive care which would ultimately lead to improved or better 
health related quality of life [12, 13].  
2. Methodology 
2.1 Study Design and Setting 
A quantitative questionnaire based cross-sectional survey was undertaken in outpatient departments of Sandeman 
Provisional Hospital (SPH) Quetta. The hospital provides services to majority of the city and provincial population.  
2.2 Participants and Sampling Criteria 
The estimated prevalence of hypertension in Balochistan has never been reported for which the sample size cannot 
be determined on the basis of prevalence. Addressing the current situation convenience data sampling technique 
was used and therefore 400 hypertensive patients were approached for the data collection. 
Patients of age 18 or above having a documented diagnosis of hypertension for past 6 months or longer and were 
prescribed one or more antihypertensive medications were included in the study. Moreover, those hypertensive 
patients who understand Urdu language and were conscious with no mental incapacity and willing to participate 
were also included in the study. Patients having co morbidities, critically ill or hospitalized were not included in 
the study. Pregnant ladies were also excluded from the study as these all conditions influence HRQOL along with 
hypertension and that would make the results biased.  
2.3 Ethical Consideration 
The national bioethical committee guidelines for researches involving humans were followed and therefore was 
reviewed and approved by Research Committee from Department of Pharmacy Practice, Faculty of Pharmacy and 
Health Sciences, University of Balochistan. Furthermore, approval was also granted from Medical Superintendent 
of the Hospital. Patients consent was also given a priority and confidentiality of their information was maintained. 
2.4 Study Instrument 
Health Related Quality of Life was assessed by EuroQoL-5D-3L, which is a generic instrument for the 
measurement of health outcomes such as HRQoL (EuroQol-Group, 1990). This HRQoL determining tool consists 
of two parts, of which the first part contains five domains (mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression), and the second part consists of 20cm health meter called as EQ-VAS (Visual Analogue Scale). 
Each of 5 domains of first part of EQ-5D are measured by three levels of severity i.e. no problems, some or 
moderate problems and extreme problems. Responses to these five items are used to obtain the weighted EQ-5D 
index score, which demonstrate health state with a possible range from 0.594 to 1.0. The EQ-VAS (Visual 
Analogue Scale) consists of two distinct endpoints, the best imaginable health state (score of 100) and the worst 
imaginable health state (score of zero). EQ-5D was scored in accordance with the criteria designed by EuroQoL.  
2.5 Data Analysis 
The coded data was entered and were analyzed by using SPSS v. 20. Descriptive analysis was used for the patients’ 
characteristics and EQ-5D health status. Chi-square test was applied as an inferential statistical test to determine 
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3. Results 
3.1 Study Population Characteristics 
Out of 400 patients of hypertension 357 consented to participate in study out of which, 263 patients fulfilled the 
inclusion criteria. Patient characteristics demonstrates that majority (25%) of the respondents were of age group 
48 -75 years old and were married 73.4%. Most of the patients 37.3% (n=98) had no income while 24% (n=63) of 
patients had monthly income above 30,000 Pakistani Rupees as displayed in Table 1. 
 
Table 1. Characteristics of Study Participants 
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3.2 EQ5D Health Status 
The hypertensive patients receiving pharmacotherapy have reported more than 60 different EQ-5D health states 
out of which 26 are mentioned in the Table 2 with bulk of respondents (8.7%) had no problem in first three domains 
while having some problem in pain and anxiety domains. Following them 7.6% of patients had some problems in 
all domains of the EQ5D tool.  
Table 3 shows that majority of the study participants showed no problems in mobility (52.9 %, n=139) and in 
taking care of themselves (65%, n=171). The table also demonstrates that most of the participants have some 
problems in performing their usual activities (47.9%, n= 126). Additionally, bulk of study respondents had 
moderate ache (n=169, 64.3%) and were having moderate level of anxiety and/or depression (46.4%, n=122). 
 
Table 2. Self-Reported EQ5D Health States 
S. No. Health status Frequency n=263 Percentage (%) 
1 11122 23 8.7 
2 22222 20 7.6 
3 11111 18 6.8 
4 11121 16 6.1 
5 11222 13 4.9 
6 11112 9 3.4 
7 11223 9 3.4 
8 12221 9 3.4 
9 21122 9 3.4 
10 21121 6 2.3 
11 21123 6 2.3 
12 22232 4 1.5 
13 12112 3 1.1 
14 12211 3 1.1 
15 11123 3 1.1 
16 11211 3 1.1 
17 32232 3 1.1 
18 11221 3 1.1 
19 22233 3 1.1 
20 31333 3 1.1 
21 12212 3 1.1 
22 21112 3 1.1 
23 12222 3 1.1 
24 12323 3 1.1 
25 11212 2 0.8 
26 11113 2 0.8 
 
Table 3. EQ5D Domains 
EQ5D Domain Frequency n=263 Percentage 
Mobility 
I have no problems in walking about 
I have some problems in walking about 










I have no problems with self-care 
I have some problems washing or dressing myself 









Usual Activities  
I have no problems with performing my usual activities 
I have some problems with performing my usual activities 
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Pain / Discomfort  
I have no pain or discomfort 
I have moderate pain or discomfort 









Anxiety / Depression  
I am not anxious or depressed 
I am moderately anxious or depressed 










3.3 Impact of Antihypertensive Agents on Health Status 
The Table 4 of the impact of drugs on HRQoL shows ACE Inhibitors and Diuretics significantly influence the 
health status of hypertensive patients acquiring pharmacotherapy. 
 
Table 4. Association of Antihypertensive agents with Heath Status and VAS Score 
Drugs used Frequency EQ5D-score VAS-score 
  Mean SD± P-value Mean SD P-value 
ACE Inhibitors 100 0.436 0.409 0.008 63.60 13.65 0.012 
ARB 47 0.566 0.327 0.198 62.45 13.14 0.255 
DIU 53 0.370 0.440 0.005 61.04 16.50 0.004 
BB 136 0.476 0.364 0.082 62.99 12.4 0.114 
CCB 115 0.498 0.345 0.318 64.70 12.1 0.816 
VD 71 0.514 0.329 0.768 65.86 11.03 0.290 
LOP 149 0.470 0.389 0.061 63.87 12.5 0.099 
STA 101 0.451 0.388 0.013 61.83 13.1 0.012 
SSRI 6 0.611 0.422 0.380 71.67 13.2 0.290 
 
4. Discussion  
The influence of treatment of hypertension on quality of life has been scarcely investigated in population-based 
surveys. Yan et al found significant improvements in HRQoL during BP control therapies [14]. Similar results 
were obtained that drug interventions would considerably relieve symptoms, comfort patients’ anxiety, and 
improved their self-reported quality of life. [14,15]. Other studies, in contrast, have reported no or even adverse 
influences of BP lowering therapies on HRQoL [14,15]. Some studies have shown that changes in HRQoL vary 
by antihypertensive treatment [16]. 
The study determined that health related quality of life was affected in participants with hypertension under 
antihypertensive treatment. The association of drug treatment with health-related quality of life has been attributed 
pharmacological and adverse effects of BP-lowering drugs. The short-term impact of antihypertensive therapy on 
quality of life can be appraised [14]. Erickson et al and Trivisol reported lower health related quality of life due to 
symptoms associated with drug treatment [17,18]. Chung et al compared three antihypertensive therapies in a 
randomized clinical trial, while the three treatments showed no difference in the primary outcome, the results 
showed major differences in health-related quality of life [11]. On the other hand, Antihypertensive treatment has 
a positive effect on the health-related quality of life indicators, a positive effect that may be due to the drug effect 
or to the placebo effect [19].  
The current study used a universally accepted tool for the assessment of quality of life, which is essential for 
demonstrating the overall trend and it was found in the present study that antihypertensives have an influence on 
health-related quality of life. The association of drug treatment with lower quality of life has not been attributed 
to adverse effects of BP-lowering drugs as a whole or to a group of agents. The TOHMS trial, which followed 
more than 1000 individuals randomized to four classes of blood agents and placebo for four years, did not find any 
difference in several scores of quality of life between participants who received active drugs or placebo [18,20]. 
From the findings of the present study, two of the antihypertensive drug groups i.e., diuretics and angiotensin 
converting enzymes ACE’s, showed significant association with health-related quality of life. In support of 
significant effect of diuretics on health-related quality of life most of the studies indicate negative effect of diuretics 
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on health-related quality of life which may be due to altering urinary frequency, erectile disorder, muscle cramps 
and fatigue or inadequate symptomatic relief with diuretics drugs [21]. 
Croog et al evaluated the effect of thiazide diuretic alone or in combination with other antihypertensives lead to 
decreased health related quality of life scores [22]. 
However, much of the criticism on quality of life with thiazides is based on the use of (too) high doses [20, 23]. 
Age dependent significance of diuretic was reported in older patients with better health related quality of life [24]. 
The studies that have examined the quality-of-life aspects of ACE inhibitors have usually reported favorable results, 
although most of these studies were not necessarily directed towards patients with hypertension [25]. ACE 
inhibitors seem to be effective in maintaining or even improving cognitive function through mechanisms other 
than blood pressure reduction [26]. In particular, patients taking captopril experienced less sexual dysfunction and 
had higher scores on measures of general well-being and life satisfaction, work performance and cognitive function 
[27]. 
In case of supportive therapy statins showed significant effects, Discontinuation of statin treatment was associated 
with better quality of life [28]. On the other side Statin treatment has beneficial effects on vascular function [29], 
and generally low frequency of real adverse effects [30], all of which would be mechanisms to affect health related 
quality of life. One of the octogenarian studies, community-dwelling men showed no significant difference in the 
health-related quality of life between statin users and nonusers [31]. 
The TOHMS trial, which followed more than 1000 individuals randomized to four classes of blood agents and 
placebo for four years, did not find any difference in several scores of quality of life between participants who 
received active drugs or placebo [18], [20]. 
5. Conclusion 
It was concluded by the present study that antihypertensive agents have a significant impact on HRQoL of 
hypertensive patients. The Angiotensin Converting Enzyme Inhibitors and Diuretics show significant impact on 
HRQoL of hypertensive patients. However, it is also suggested to assess the impact of antihypertensive therapies 
given in combination must also be studied in order to provide health professionals a better understanding of their 
prescribed regimen to improve patient related health outcomes.  
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